journal article·2016-02-23

Size-Tuning Ionization To Optimize Gold Nanoparticles for Simultaneous Enhanced CT Imaging and Radiotherapy

Yan Dou, Yanyan Guo, Xiaodong Li, Xue Li, Sheng Wang, Lin Wang, Guoxian Lv, Xuening Zhang, Hanjie Wang, Xiaoqun Gong, Jin Chang

ACS Nano· Volume 10· Issue 2
Publisher page

Abstract

Computed tomography (CT) contrast and radiosensitization usually increase with particle sizes of gold nanoparticles (AuNPs), but there is a huge challenge to improve both by adjusting sizes under the requirements of in vivo application. Here, we report that AuNPs have great size-dependent enhancements on CT imaging as well as radiotherapy (RT) in the size range of 3-50 nm. It is demonstrated that AuNPs with a size of ∼13 nm could simultaneously possess superior CT contrast ability and significant radioactive disruption. The Monte Carlo method is further used to evaluate this phenomenon and indicates that the inhomogeneity of gold atom distributions caused by sizes may influence secondary ionization in whole X-ray interactions. In vivo studies further indicate that this optimally sized AuNP improves real-time CT imaging and radiotherapeutic inhibition of tumors in living mice by effective accumulation at tumors with prolonged in vivo circulation times compared to clinically used small-molecule agents. These results suggest that ∼13 nm AuNPs may serve as multifunctional adjuvants for clinical X-ray theranostic application.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Radiation Therapy and Dosimetry · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Material Science and Engineering, School of Life Sciences, Tianjin University, Tianjin Engineering Center of Micro-Nano Biomaterials and Detection-Treatment Technology, and Collaborative Innovation Center of Chemical Science and Engineering, Tianjin 300072, People’s Republic of China

Department of Radiation Oncology and Department of Radiology, The Second Hospital of Tianjin Medical University, Tianjin 300211, People’s Republic of China

Funding

Natural Science Foundation of Tianjin City · Ministry of Education of the People's Republic of China · Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China

References (52)

Show source-provided references
1. 10.1200/JCO.2007.14.514410.1200/JCO.2007.14.5144 ↗
2. 10.1038/nrclinonc.2012.20810.1038/nrclinonc.2012.208 ↗
3. 10.1016/j.radonc.2013.03.00710.1016/j.radonc.2013.03.007 ↗
4. 10.1021/acsnano.5b0460610.1021/acsnano.5b04606 ↗
5. 10.1002/adma.20150300610.1002/adma.201503006 ↗
6. 10.1038/nnano.2009.31410.1038/nnano.2009.314 ↗
7. 10.1039/C2CS15261D10.1039/C2CS15261D ↗
8. 10.1158/0008-5472.CAN-04-392110.1158/0008-5472.CAN-04-3921 ↗
9. 10.1038/srep0175110.1038/srep01751 ↗
10. 10.1021/ja404985w10.1021/ja404985w ↗
11. 10.1002/adhm.20120003210.1002/adhm.201200032 ↗
12. 10.1016/j.biomaterials.2011.10.05210.1016/j.biomaterials.2011.10.052 ↗
13. 10.7150/thno.944810.7150/thno.9448 ↗
14. 10.2217/nnm.12.16510.2217/nnm.12.165 ↗
15. 10.1039/c3nr06694k10.1039/c3nr06694k ↗
16. 10.1016/j.biomaterials.2012.11.01010.1016/j.biomaterials.2012.11.010 ↗
17. 10.1002/adhm.20130018910.1002/adhm.201300189 ↗
18. 10.1016/j.biomaterials.2011.08.08610.1016/j.biomaterials.2011.08.086 ↗
19. 10.1016/j.jconrel.2009.07.00710.1016/j.jconrel.2009.07.007 ↗
20. 10.1002/adma.20130008110.1002/adma.201300081 ↗
21. 10.1158/0008-5472.CAN-08-424210.1158/0008-5472.CAN-08-4242 ↗
22. 10.1021/cm800841810.1021/cm8008418 ↗
23. 10.1016/j.biomaterials.2012.05.04710.1016/j.biomaterials.2012.05.047 ↗
24. 10.1016/j.addr.2009.03.00510.1016/j.addr.2009.03.005 ↗
25. 10.1016/j.addr.2012.09.03310.1016/j.addr.2012.09.033 ↗
26. 10.1016/j.pneurobio.2008.09.00910.1016/j.pneurobio.2008.09.009 ↗
27. 10.1038/srep0001810.1038/srep00018 ↗
28. 10.1088/0031-9155/59/21/643110.1088/0031-9155/59/21/6431 ↗
29. 10.1080/01621459.1949.1048331010.1080/01621459.1949.10483310 ↗
30. 10.1118/1.480815010.1118/1.4808150 ↗
31. 10.1118/1.353962310.1118/1.3539623 ↗
32. 10.1021/cr980441p10.1021/cr980441p ↗
33. 10.1021/cr200358s10.1021/cr200358s ↗
34. 10.1088/0031-9155/30/2/00310.1088/0031-9155/30/2/003 ↗
35. 10.1088/0031-9155/28/9/00310.1088/0031-9155/28/9/003 ↗
36. 10.1088/0031-9155/59/24/767510.1088/0031-9155/59/24/7675 ↗
37. 10.1016/S0958-3947(99)00004-710.1016/S0958-3947(99)00004-7 ↗
38. 10.1088/0031-9155/51/21/00710.1088/0031-9155/51/21/007 ↗
39. 10.1021/acsnano.5b0132010.1021/acsnano.5b01320 ↗
40. 10.1016/j.biomaterials.2012.03.02010.1016/j.biomaterials.2012.03.020 ↗
41. 10.1016/j.taap.2010.02.01310.1016/j.taap.2010.02.013 ↗
42. 10.1038/nnano.2011.5810.1038/nnano.2011.58 ↗
43. 10.1039/c2cs15294k10.1039/c2cs15294k ↗
44. 10.1039/C0CS00018C10.1039/C0CS00018C ↗
45. 10.1038/495S14a10.1038/495S14a ↗
46. 10.1021/ja504390x10.1021/ja504390x ↗
47. Delgado C. · Crit. Rev. Ther. Drug. · 1992 · 9 · 249
48. 10.1021/la201938u10.1021/la201938u ↗
49. 10.1021/la010432310.1021/la0104323 ↗
50. 10.1118/1.59891710.1118/1.598917 ↗
51. 10.1088/0031-9155/58/22/809910.1088/0031-9155/58/22/8099 ↗
52. 10.1088/0031-9155/48/7/40110.1088/0031-9155/48/7/401 ↗